Company profile: Myogen
1.1 - Company Overview
Company description
- Provider of small molecule therapeutics for cardiovascular disorders, focused on the discovery, development and commercialization of treatments, combining advanced understanding of cardiovascular disease biology with clinical development expertise in cardiovascular therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Myogen
Deltex Medical
HQ: United Kingdom
Website
- Description: Provider of haemodynamic monitoring solutions using oesophageal Doppler technology, including the TrueVue system with improved signal acquisition, intuitive software and HD touchscreen controls; ODM+ devices to guide fluid and drug administration; the NICE-recommended CardioQ-ODM; plus e-learning courses and an Oesophageal Doppler Simulator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deltex Medical company profile →
Enchannel
HQ: China
Website
- Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enchannel company profile →
InteloMed
HQ: United States
Website
- Description: Provider of non-invasive, real-time cardiopulmonary monitoring solutions. Offers InteloMed TeleHealth Technology that uses facial scans during virtual consultations to deliver pulse and respiration metrics to clinicians. Engages in a NASA-supported project to develop non-contact monitoring for personnel and conducts an IRB-reviewed clinical study to validate its algorithms against traditional methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InteloMed company profile →
PLC Medical Systems
HQ: United States
Website
- Description: Provider of health care solutions as a Health Care company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PLC Medical Systems company profile →
HeartBeam
HQ: United States
Website
- Description: Provider of a 3D-vector electrocardiogram (VECG) platform for remote cardiac monitoring and 12-lead ECG generation. Offerings include HeartBeam AIMIGo, a portable credit card-sized device that captures and converts heart electrical signals to a 12-lead ECG; core VECG technology delivering diagnostic and prognostic insights; HeartBeam Cloud Service for analysis and on-call physician review; and the AIMIGo App guiding recording and transmission.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartBeam company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Myogen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Myogen
2.2 - Growth funds investing in similar companies to Myogen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Myogen
4.2 - Public trading comparable groups for Myogen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →